[1] JONES LC, HUNGERFORD DS. Osteonecrosis: etiology, diagnosis, and treatment. Curr Opin Rheumatol. 2004;16(4):443-449.
[2] WU X, SUN W, TAN M. Noncoding RNAs in Steroid-Induced Osteonecrosis of the Femoral Head. Biomed Res Int. 2019;2019: 8140595.
[3] WELDON D. The effects of corticosteroids on bone: osteonecrosis (avascular necrosis of the bone). Ann Allergy Asthma Immunol. 2009; 103(2):91-133.
[4] LIU Y, MO L, LU H, et al. Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways. Front Cell Dev Biol. 2023;11:1202888.
[5] CHAI JL, LU BW, DU HT, et al. Pyroptosis -related potential diagnostic biomarkers in steroid-induced osteonecrosis of the femoral head. BMC Musculoskelet Disord. 2023;24(1):609.
[6] KONARSKI W, POBOŻY T, KONARSKA K, et al. Osteonecrosis Related to Steroid and Alcohol Use-An Update on Pathogenesis. Healthcare (Basel). 2023;11(13):1846.
[7] YAMAMOTO T, IWAMOTO Y. Corticosteroids treatments and osteonecrosis of the femoral head. Fukuoka Igaku Zasshi. 2015;106(3):47-53.
[8] WEINSTEIN RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41(2):183-190.
[9] PAVELKA K. Osteonecrosis. Baillieres Best Pract Res Clin Rheumatol. 2000;14(2):399-414.
[10] ZOFKOVÁ I, NEMCIKOVA P, MATUCHA P. Trace elements and bone health. Clin Chem Lab Med. 2013;51(8):1555-1561.
[11] MILACHOWSKI KA. Investigation of ischaemic necrosis of the femoral head with trace elements. Int Orthop. 1988;12(4):323-330.
[12] WANG L, ZHANG L, GAO M. Metabolic Disorders and Mineral Density of the Bone Tissue in the Early Pathogenesis of Osteonecrosis: Study on Rabbits with Steroid-Induced Osteonecrosis. Bull Exp Biol Med. 2021;170(6):724-728.
[13] ZHENG LZ, WANG JL, XU JK, et al. Magnesium and vitamin C supplementation attenuates steroid-associated osteonecrosis in a rat model. Biomaterials. 2020;238:119828.
[14] BOCANEGRA-PÉREZ MS, VICENTE-BARRERO M, SOSA-HENRÍQUEZ M, et al. Bone metabolism and clinical study of 44 patients with bisphosphonate-related osteonecrosis of the jaws. Med Oral Patol Oral Cir Bucal. 2012;17(6):e948-e955.
[15] LORENZO-POUSO AI, PÉREZ-SAYÁNS M, GARCÍA A, et al. Vitamin D supplementation: Hypothetical effect on medication-related osteonecrosis of the jaw. Med Hypotheses. 2018;116:79-83.
[16] YANG J, WU W, AMIER Y, et al. Causal relationship of genetically predicted circulating micronutrients levels with the risk of kidney stone disease: a Mendelian randomization study. Front Nutr. 2023;10: 1132597.
[17] ZHU RC, LI FF, WU YQ, et al. Minimal effect of sleep on the risk of age-related macular degeneration: a Mendelian randomization study. Front Aging Neurosci. 2023;15:1159711.
[18] DI RESTA C, PIPITONE GB, CARRERA P, et al. Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing. Neural Regen Res. 2021;16(3):475-481
[19] ZHONG X, WANG L, XU L, et al. Disturbance of skin sensation and autism spectrum disorder: A bidirectional Mendelian randomization study. Brain Behav. 2023:e3238. doi: 10.1002/brb3.3238.
[20] SKRIVANKOVA VW, RICHMOND RC, WOOLF BAR, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021; 326(16):1614-1621.
[21] 熊海安,刘晓玲,白植宝.上颌骨双磷酸盐相关性骨坏死临床观察[J].青海医药杂志,2020,50(5):74-76.
[22] ENDO T, FUNAYAMA H, YAMAGUCHI K, et al. Basic studies on the mechanism, prevention, and treatment of osteonecrosis of the jaw induced by bisphosphonates. Yakugaku Zasshi. 2020;140(1):63-79.
[23] MÜLLER WEG, ACKERMANN M, AL-NAWAS B, et al. Amplified morphogenetic and bone forming activity of amorphous versus crystalline calcium phosphate/polyphosphate. Acta Biomater. 2020; 118:233-247.
[24] HUGHES EAB, ROBINSON TE, BASSETT DB, et al. Critical and diverse roles of phosphates in human bone formation. J Mater Chem B. 2019; 7(47):7460-7470.
[25] PAZARÇEVIREN AE, TEZCANER A, KESKIN D, et al. Boron-doped Biphasic Hydroxyapatite/β-Tricalcium Phosphate for Bone Tissue Engineering. Biol Trace Elem Res. 2021;199(3):968-980.
[26] THOMAS J, WORCH H, KRUPPKE B, et al. Contribution to understand the biomineralization of bones. J Bone Miner Metab. 2020;38(4):456-468.
[27] GILBERT AK, NEWTON TD, HETTIARATCHI MH, et al. Reactive sulfur and selenium species in the regulation of bone homeostasis. Free Radic Biol Med. 2022;190:148-157.
[28] WANG N, XIE D, WU J, et al. Selenium and bone health: a protocol for a systematic review and meta-analysis. BMJ Open. 2020;10(10):e036612.
[29] 胡一新,石小兵,谢润琪,等.绝经后女性血清硒水平与骨质疏松骨密度和骨代谢指标相关性研究[J].中国骨质疏松杂志,2021, 27(9):1329-1332.
[30] KURIBAYASHI M, FUJIOKA M, TAKAHASHI KA, et al. Vitamin E prevents steroid-induced osteonecrosis in rabbits. Acta Orthop. 2010;81(1): 154-160.
[31] AGHAJANIAN P, HALL S, WONGWORAWAT MD, et al. The Roles and Mechanisms of Actions of Vitamin C in Bone: New Developments. J Bone Miner Res. 2015;30(11):1945-1955.
[32] REID IR. Nutrition and bone health: the case of selenium. Lancet Healthy Longev. 2021;2(4):e185-e186.
[33] YANG T, LEE SY, PARK KC, et al. The Effects of Selenium on Bone Health: From Element to Therapeutics. Molecules. 2022;27(2):392.
[34] DENG H, LIU H, YANG Z, et al. Progress of Selenium Deficiency in the Pathogenesis of Arthropathies and Selenium Supplement for Their Treatment. Biol Trace Elem Res. 2022;200(10):4238-4249.
[35] YAZICI T, KOÇER G, NAZIROĞLU M, et al. Zoledronic Acid, Bevacizumab and Dexamethasone-Induced Apoptosis, Mitochondrial Oxidative Stress, and Calcium Signaling Are Decreased in Human Osteoblast-Like Cell Line by Selenium Treatment. Biol Trace Elem Res. 2018;184(2):358-368.
[36] WONG SK, MOHAMAD NV, IBRAHIM N’, et al. The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence. Int J Mol Sci. 2019;20(6):1453.
[37] GHARANIZADEH K, AMINIZADEH S, MOLAVI N, et al. Effects of Zoledronic Acid and Vitamin E on Surgical- Induced Osteonecrosis of the Femoral Head in Rabbit. Arch Bone Jt Surg. 2018;6(6):547-553.
[38] JIA YB, JIANG DM, REN YZ, et al. Inhibitory effects of vitamin E on osteocyte apoptosis and DNA oxidative damage in bone marrow hemopoietic cells at early stage of steroid-induced femoral head necrosis. Mol Med Rep. 2017;15(4):1585-1592. |